MA53138B1 - 3-(5-HYDROXY-1-OXOISOINDOLINE-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2) DEPENDENT DISEASES - Google Patents

3-(5-HYDROXY-1-OXOISOINDOLINE-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2) DEPENDENT DISEASES

Info

Publication number
MA53138B1
MA53138B1 MA53138A MA53138A MA53138B1 MA 53138 B1 MA53138 B1 MA 53138B1 MA 53138 A MA53138 A MA 53138A MA 53138 A MA53138 A MA 53138A MA 53138 B1 MA53138 B1 MA 53138B1
Authority
MA
Morocco
Prior art keywords
ikzf2
treatment
zinc finger
oxoisoindoline
piperidine
Prior art date
Application number
MA53138A
Other languages
French (fr)
Other versions
MA53138A (en
Inventor
Noel Marie-France Thomsen
Michael Scott Visser
Simone Bonazzi
Artiom Cernijenko
Claire Adcock
Philip Lam
Kathryn Taylor Linkens
Hasnain Ahmed Malik
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/IB2019/055804 external-priority patent/WO2020012334A1/en
Publication of MA53138A publication Critical patent/MA53138A/en
Publication of MA53138B1 publication Critical patent/MA53138B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un composé de formule (i') : ou un sel, un hydrate, un solvate, un promédicament, un stéréoisomère ou un tautomère pharmaceutiquement acceptable de celui-ci, dans laquelle rx, x1, x2, et r1 sont tels que définis dans la description, et son utilisation dans le traitement de maladies dépendantes du doigt de zinc 2 de la famille ikaros (ikzf2).The present invention relates to a compound of formula (i'): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer or tautomer thereof, wherein rx, x1, x2, and r1 are such as defined in the description, and its use in the treatment of diseases dependent on zinc finger 2 of the ikaros family (ikzf2).

MA53138A 2018-07-10 2019-07-08 3-(5-HYDROXY-1-OXOISOINDOLINE-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2) DEPENDENT DISEASES MA53138B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862695920P 2018-07-10 2018-07-10
PCT/IB2019/055804 WO2020012334A1 (en) 2018-07-10 2019-07-08 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases

Publications (2)

Publication Number Publication Date
MA53138A MA53138A (en) 2021-05-19
MA53138B1 true MA53138B1 (en) 2023-10-31

Family

ID=75905122

Family Applications (1)

Application Number Title Priority Date Filing Date
MA53138A MA53138B1 (en) 2018-07-10 2019-07-08 3-(5-HYDROXY-1-OXOISOINDOLINE-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2) DEPENDENT DISEASES

Country Status (2)

Country Link
AR (1) AR116110A1 (en)
MA (1) MA53138B1 (en)

Also Published As

Publication number Publication date
MA53138A (en) 2021-05-19
AR116110A1 (en) 2021-03-31

Similar Documents

Publication Publication Date Title
MA49952B1 (en) 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
PH12021550045A1 (en) 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
MA47368B1 (en) N- [4-fluoro-5 - [[(2s, 4s) -2-methyl-4 - [(5-methyl-1,2,4-oxadiazol-3-yl) methoxy] -1-piperidyl] methyl] thiazol-2-yl] acetamide used as an inhibitor of yoga
MX2020001776A (en) SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP<sub>3</sub> INHIBITORS.
CR20200588A (en) Novel compounds
GEP20237561B (en) Protein tyrosine phosphatase inhibitors
MA30433B1 (en) PYRAZOLO [3,4-D] PYRIMIDINE DERIVATIVES FOR TREATING RESPIRATORY DISORDERS
MA46337B1 (en) Pyridine compound
MA42339A1 (en) Farnesoid Receptor Modulators x
MA43169B1 (en) Heterocyclic compounds as pi3k-gamma inhibitors
MA45888A1 (en) Bruton tyrosine kinase inhibitors
MA45020B1 (en) Aromatic sulfonamide derivatives
MA46101A (en) POSITIVE ALLOSTERIC MODULATORS OF THE M1 MUSCARINIC RECEPTOR
EA202192900A1 (en) MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAYS
MA51431B1 (en) Oxy-fluoropiperidine derivatives used as kinase inhibitor
PH12020550168A1 (en) Griseofulvin compound and pharmaceutical use thereof
MA41494A (en) BENZOXABOROLE COMPOUNDS SUBSTITUTED IN POSITION 4 AND ASSOCIATED USES
EA201992090A1 (en) Deuterated Imidazo [4,5-c] Quinolin-2-One Compounds and Their Use in Cancer Treatment
MX2021008632A (en) Cyclic molecules as bruton's tyrosine kinase inhibitor.
EA202092253A1 (en) SUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS PRMT5 INHIBITORS
MA50069B1 (en) 1-(4-(ISOXAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPAN-2-OL DERIVATIVES AND SIMILAR COMPOUNDS AS IL-7 AND IFN-GAMMA INHIBITORS FOR THE TREATMENT OF DISEASES AUTOIMMUNE AND CHRONIC INFLAMMATION
MX2020008523A (en) Compound having s1p5 receptor agonist activity.
MX2022004912A (en) Novel substituted condensed ring compound.
MA53138B1 (en) 3-(5-HYDROXY-1-OXOISOINDOLINE-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2) DEPENDENT DISEASES
EA202191349A1 (en) 1,3,4-OXADIAZOLONE AND PHARMACEUTICAL PREPARATION